GENZYME - THE KING OF THE BIOTECHS Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GENZYME - THE KING OF THE BIOTECHS

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: aliveinsf who wrote (312)	7/28/1998 5:38:00 PM
From: Caveat Emptor	Read Replies (1) of 410

What is the status of ATRAGEN? What are the projections for when this product will be profitable, or even be approved? Genzyme dumped 4.5 million into it in 1993, and it doesn't seem to be mentioned much. (Genzyme) also took a ton a ARONEX Stock in exchange for the equity investment into the collaboration agreeement. By the way, ARONEX has not traded much lately, and is close to $2.00 a share... almost off the NASDAQ board. As I mentioned in a previous post, Geoffrey Cox was transferred over there to run that company, but in his first year, millions of dollars richer because of Genzyme Stock Sales in 1997, he has not made much of a difference.... Is this product another management misfire, or is there something there? CAVEAT EMPTOR

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next